Literature DB >> 2154350

Properties and origin of osteoblasts.

K H Włodarski1.   

Abstract

Osteoblastic and chondroblastic (i.e., osteogenic) cells belong to the stromal cell system, which is associated with bone marrow, and bone and is separate from the hematopoietic stem-cell system. Stromal stem cells are capable of producing reticular, fibroblastic, osteogenic, and adipose stromal lines. Marrow-derived osteogenic cells are a component of marrow stroma, which in vitro form fibroblastic-type colonies. These colonies are a heterogeneous population with varying enzymatic expressions and potencies that differentiate into fibroblastic, reticular, adipocytic, and osteogenic populations. It is postulated that these colonies are a component of the stem- and progenitor cell populations. Progenitors of osteogenic cells are widely distributed in the extraskeletal organs. On contact with an adequate inductor, they differentiate into chondro- and/or osteoblasts, thus producing ectopic (i.e., induced) cartilage and/or bone. Such osteoprogenitor cells were termed inducible osteoprogenitor cells, in contrast to the determined osteoprogenitor cells, which are present in the bone marrow stroma and produce bone spontaneously. To the class of determined osteoprogenitors also belong endosteal cells, periosteal cells, and osteoblastic established cell lines. There is no evidence of the presence of osteogenic cells in the blood and peritoneal fluid. The concept of mesenchymal cells as an osteoblastic precursor in adult organisms is open to question.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2154350

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  9 in total

1.  CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency.

Authors:  Reem Smoum; Saja Baraghithy; Mukesh Chourasia; Aviva Breuer; Naama Mussai; Malka Attar-Namdar; Natalya M Kogan; Bitya Raphael; Daniele Bolognini; Maria G Cascio; Pietro Marini; Roger G Pertwee; Avital Shurki; Raphael Mechoulam; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

2.  C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation.

Authors:  Yulan Zhao; Mu Xiao; Baoguo Sun; Zhengmao Zhang; Tao Shen; Xueyan Duan; Paul Borchyung Yu; Xin-Hua Feng; Xia Lin
Journal:  J Biol Chem       Date:  2014-08-06       Impact factor: 5.157

3.  Local administration of IKK small molecule inhibitor may enhance fracture healing in osteoporosis patient.

Authors:  Duanyang Han; Peixun Zhang; Baoguo Jiang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

4.  Filling the bone defect with osteogenic material. An experimental study.

Authors:  H Göransson; J Vuola; M Linden; H Pätiälä; P Rokkanen
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

5.  Induction of early growth response-1 gene by interleukin-1 beta and tumor necrosis factor-alpha in normal human bone marrow stromal an osteoblastic cells: regulation by a protein kinase C inhibitor.

Authors:  L R Chaudhary; S L Cheng; L V Avioli
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

6.  Dexamethasone regulates IL-1 beta and TNF-alpha-induced interleukin-8 production in human bone marrow stromal and osteoblast-like cells.

Authors:  L R Chaudhary; L V Avioli
Journal:  Calcif Tissue Int       Date:  1994-07       Impact factor: 4.333

7.  Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk.

Authors:  Iván Cárcamo-Orive; Ainhoa Gaztelumendi; Jesús Delgado; Naiara Tejados; Akaitz Dorronsoro; Jon Fernández-Rueda; Daniel J Pennington; César Trigueros
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

8.  Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.

Authors:  M H-C Sheng; K-H W Lau
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.207

9.  Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.

Authors:  T Katagiri; A Yamaguchi; M Komaki; E Abe; N Takahashi; T Ikeda; V Rosen; J M Wozney; A Fujisawa-Sehara; T Suda
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.